ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion.

scientific article

ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CANLET.2004.05.023
P698PubMed publication ID15488643

P2093author name stringJie Zheng
Ling Chen
Hong-mei Li
Jiang-feng You
Wei-gang Fang
Wan-jie Heng
Hui-ying He
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectprostate cancerQ181257
tumor invasionQ60750433
P304page(s)239-247
P577publication date2004-11-01
P1433published inCancer LettersQ326372
P1476titleERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion.
P478volume215

Reverse relations

cites work (P2860)
Q33873659ATP-P2Y2-β-catenin axis promotes cell invasion in breast cancer cells
Q90055497Antiproliferative and Anti-invasion Effects of Carvacrol on PC3 Human Prostate Cancer Cells through Reducing pSTAT3, pAKT, and pERK1/2 Signaling Proteins
Q38567609CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins
Q37198990Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors.
Q98158767Extracellular ATP promotes breast cancer invasion and chemoresistance via SOX9 signaling
Q39538019Gadolinium inhibits prostate cancer PC3 cell migration and suppresses osteoclast differentiationin vitro
Q26991904Important roles of P2Y receptors in the inflammation and cancer of digestive system
Q35540734Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain.
Q60936264Involvement of the glutamine RF‑amide peptide and its cognate receptor GPR103 in prostate cancer
Q33369573MAP kinase pathways and calcitonin influence CD44 alternate isoform expression in prostate cancer cells
Q54999827MiR-1271 Inhibits Cell Growth in Prostate Cancer by Targeting ERG.
Q36174261Nucleotide receptor signalling and the generation of reactive oxygen species
Q37677827Nucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT).
Q41895729P2 receptors in renal pathophysiology
Q35500124P2X7 mediates ATP-driven invasiveness in prostate cancer cells
Q35693663P2Y2 Receptor and EGFR Cooperate to Promote Prostate Cancer Cell Invasion via ERK1/2 Pathway
Q37182251P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells
Q47634604P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT-related genes Snail and E-cadherin
Q52936872Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer.
Q24618782Purinergic signalling and cancer
Q38061933Purinergic signalling in the lower urinary tract
Q26820842Purinergic signalling in the reproductive system in health and disease
Q37392558Role of p38 MAP Kinase Signal Transduction in Solid Tumors
Q39847370Suppression of ErbB-2 in androgen-independent human prostate cancer cells enhances cytotoxic effect by gemcitabine in an androgen-reduced environment
Q53244075The activation of P2Y2 receptors increases MCF-7 breast cancer cells migration through the MEK-ERK1/2 signalling pathway.
Q92770702The protective role of the MKP-5-JNK/P38 pathway in glucolipotoxicity-induced islet β-cell dysfunction and apoptosis
Q97435733Using Cytometry for Investigation of Purinergic Signaling in Tumor-Associated Macrophages
Q48144894p38 differentially regulates ERK, p21, and mitogenic signalling in two pancreatic carcinoma cell lines

Search more.